Skip to main content
. Author manuscript; available in PMC: 2015 Jan 13.
Published in final edited form as: Invest New Drugs. 2014 Mar 27;32(4):739–745. doi: 10.1007/s10637-014-0083-8

Table 1.

Baseline Patient Characteristics

Variable Total Patients (N = 18)
Sex
    Male N (%) 8 (44)
    Female 10 (56)
Ethnicity/Race
    Hispanic N (%) 2 (11)
    NH White 15 (83)
    NH Black 1 (6)
Age
    Years Mean (SD) 65.0 (11.9)
(Min, Max) (46, 80)
Med (Q1, Q3) 67 (58, 77)
ECOG Performance Status
    0 N (%) 4 (22)
    1 13 (72)
    2 1 (6)
Previous Chemotherapy
    Regimens Mean (SD) 2.4 (1.1)
(Min, Max) (1, 5)
Med (Q1, Q3) 2 (2, 3)
Previous Therapy
    Chemotherapy N (%) 18 (100)
    Radiotherapy 9 (50)
    Surgery (Curative Intention) 7 (39)
    Immunotherapy 3 (17)